Searchable abstracts of presentations at key conferences in endocrinology

ea0049gp111 | Diabetes therapy & complications 2 | ECE2017

Hepatic effects of GLP-1 receptor agonist Liraglutide in patients with type 2 diabetes

Hayon Maria , Fernandez Marta , Maraver Silvia , Muros Teresa , Cepero Daniel , Lopez Martin , Quesada Miguel , Pechuan Joaquin , Piedrola Gonzalo

Introduction: The aim of this study was to analyze the effects of Liraglutide in hepatic steatosis as well as clinical and biochemical data before and after 6 months.Methods: We have retrospectively analysed epidemiological, anthropometric and laboratory data of 83 type 2 diabetic patients treated with Liraglutide and followed at different endocrinology units across east Andalusia. We have evaluated nonalcoholic fatty liver disease using liver enzymes an...